CaineM., RatzS., IieglerM.: Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Brit. J. Urol., 47; 193–202 (1975).
2.
CaineM., PfanA., PerlbergS.: The use of alpha-adrenergic blockers in benign prostatic obstruction. Brit. J. Urol., 48; 255–263 (1976).
3.
CaineM.: The importance of adrenergic receptors in disorders of micturition. Eur. Urol., 3; 1–6 (1977).
4.
ArcariG., DorigottiL., FregnanG. B., GlasserA. H.: Vasodilatating and alpha-receptor blocking activity of a new ergoline derivative. Brit. J. Pharmacol., 34; 700 (1968).
5.
TanagoE. A., MeyersF. H., SmithD. R.: Urethral resistance, its components and implications. Smooth muscle components. Invest. Urol., 7; 136–199 (1969).
6.
RaztS., CaineM.: Adrenergic receptors in the female canine urethra. Invest. Urol., 9; 319–323 (1972).
7.
RaztS.: Pharmacological treatment of lower urinary tract disfunction. Urol. Clin. N. Amer., 5; 323–324 (1978).
8.
BorehamP. F., BraithwaiteP., Milewsky: Alpha adrenergic blockers in prostatism. Brit. J. Surg., 64; 756–757 (1977).
9.
RonchiF., MargonatoA., CeccardiR., RigattiP., RossiniB. M.: Symptomatic treatment of benign prostatic obstruction with nicergoline: placebo controlled clinical study and urodynamic evaluation. Urol. Res., 10; 131–134 (1982).
